Pharmacotherapies
We provide protocols and virtual consultation services to support the delivery of evidence-based pharmacotherapies for treating opioid use disorder (OUD). This includes support with:
- Buprenorphine and methadone induction, maintenance, and taper regimens
- Evaluating opioid agonist and withdrawal effects
- Naltrexone induction and maintenance
- Sustained-release medications (e.g., 1- and 6-month buprenorphine formulations, monthly naltrexone)
- UVM CORA Resource Guide: Medications for Opioid Use Disorder (MOUD)
Clinical Support Aids
We can help you choose and implement the resources to support your patients’ treatment adherence, outcomes, and retention. We can send resources, hardware, and/or software to your practice, and provide support with their implementation and ongoing use.
- Evidence-based assessments for evaluating patient OUD severity and/or treatment needs, via paper or web-based platforms
- Biochemical monitoring of patients’ recent drug use (e.g., urine toxicology testing supplies, breathalyzer equipment)
- Best Practices Technical Assistance
Behavioral Therapies
We will help your team identify, customize, and implement evidence-based therapies for supporting your patients’ abstinence from opioids, and their clinical engagement in treatment.
- Community Reinforcement Approach: a form of behavior therapy aimed at improving family relations, learn a variety of skills to minimize drug use, receive vocational counseling, and develop new recreational activities and social networks
- Incentive-based behavioral interventions tailored to support the patient outcomes you need (e.g., medication adherence, counseling attendance, retention)
Professional Support and Educational Materials
We provide consultation, coaching, and hands-on support across a wide range of areas and platforms to any professionals seeking information, training, and resources in science-based methods.
- One-on-one virtual consultation and coaching with our Clinician Advisory Board members, who are community providers with deep expertise in treating complex patients with OUD, substance use disorders (SUDs), and other co-occurring issues
- UVM CORA Clinician Office Hours Program
- Support via phone or web-based platforms
- Expert-led seminars and video curricula with CME credits available (UVM CORA Community Rounds)
- Prevention of Opioid Use Disorder in Women
- Use of Sustained-release Buprenorphine in the Outpatient Setting
- Social Determinants of Mental Health and Substance Use
- Illicit Drug Supply: Fentanyl and Xylazine
- Nurse Practitioners and Physician Assistants as Buprenorphine Providers: Facilitators and Barriers
- Research Spotlights on the latest publications relevant to rural providers
- The Role of Stigma Among Health Care Providers in the Treatment of Opioid Use Disorder
- Increased Fatal Overdoses Involving Stimulants and Fentanyl
- Increasing Prevalence of Xylazine in Fatal Opioid Overdoses
- Expanded Naloxone Distribution to Reduce Rural Opioid Overdose Mortality
- Buprenorphine Treatment for Opioid Use Disorder in Pregnant Women
- Improving Adherence with Interim Buprenorphine Treatment
- Resource Guide of various UVM CORA-vetted sources
- A scholarship-based program to facilitate in-person training for providers and their clinical teams on science-based practices for addiction treatment
Harm Reduction
We supply resources, at no charge, for reducing the individual and public health consequences associated with OUD.
- Intranasal naloxone (Narcan) and instructions on its use
- Fentanyl detection strips, and training in their use
- UVM CORA Community Rounds videos:
- Note: The laws governing harm reduction supplies vary from state to state.
- The laws affecting possession and dissemination of naloxone, fentanyl test strips, and other harm reduction supplies may vary from state to state. By accepting supplies from UVM CORA, the recipient confirms that the supplies they are accepting are compliant with their relevant state laws. UVM CORA does not independently review the state laws for the recipient. UVM CORA will not be responsible for any losses or costs related to the recipient’s use of the harm reduction supplies.
Treament Capacity
We provide consultation, technical assistance, and ongoing support to help providers and policymakers interested in new or expanded models of care.
- Guidance on the hub-and-spoke OUD treatment model
- Low-barrier and/or interim buprenorphine treatment
- Peer support and consultation for providers and staff managing patients with complex needs
- Mentorship, support, and training for providers interested in increasing their comfort and capacity to manage MOUD
- UVM CORA Clinician Office Hours Program
- UVM CORA Clinical & Translational Scholarship Program
- Skilled Nursing Facility Staff Training Program
The above menu is not exhaustive. If you don’t see what you are looking for, reach out to us at CORA@uvm.edu with your specific needs and questions!